Disruptive Psychopharmacology
Springer International Publishing (Verlag)
978-3-031-12186-9 (ISBN)
Dosing psychedelics and MDMA.- Psychedelic Group Therapy.- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies.- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults.- Foundations for Training Psychedelic Therapists.- Ayahuasca for the Treatment of Depression.- Psilocybin for the Treatment of Depression.- Ketamine for the Treatment of Depression.- The Potential of Psychedelics for End of Life and Palliative Care.- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action.- Psilocybin for Tobacco Use Disorder.- Psychedelic Drugs as Anti-Inflammatory Agents.- Psilocybin for the Treatment of Obsessive-Compulsive Disorder.- Psilocybin for the Treatment of Headache and Pain Disorders.- Psilocybin for the Treatment of Neurodegenerative Disorders.- Psilocybin for Trauma-Related Disorders.
Erscheinungsdatum | 29.08.2023 |
---|---|
Reihe/Serie | Current Topics in Behavioral Neurosciences |
Zusatzinfo | VIII, 332 p. 100 illus., 30 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 519 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
Medizin / Pharmazie ► Studium | |
Naturwissenschaften ► Biologie ► Humanbiologie | |
Schlagworte | addiction • dementia • entactogen • Hallucinogen • Headache • inflammation • LSD • MDMA • Microdosing • Mood Disorders • Neurodevelopmental Disorders • OCD • Pain • Palliative Care • Psilocybin • Psychedelic • PTSD • Substance use disorders |
ISBN-10 | 3-031-12186-4 / 3031121864 |
ISBN-13 | 978-3-031-12186-9 / 9783031121869 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich